The ISBS 7th Symposium
STATISTICAL INNOVATION IN THE ERA OF INTEGRATED EVIDENCE FOR MEDICAL PRODUCT DEVELOPMENT
Organized by The International Society for Biopharmaceutical Statistics
The 7th International Symposium on Biopharmaceutical Statistics will take place on March 6 – 9, 2024, at Hilton Baltimore Inner Harbor. The symposium is organized by the International Society for Biopharmaceutical Statistics with a theme on “Statistical innovation in the era of integrated evidence for medical product development”. The purposes of this symposium are
- To bring together worldwide statisticians and drug development professionals who are involved in quantitative biopharmaceutical research, development, and regulations to share and exchange information, experience, and research findings, and
- To improve and promote the harmonization of statistical practice in the industry at the international front.
Prominent statisticians and drug development professionals from regulatory agencies, academia, and industry will deliver keynote speeches on various emerging/evolving fields. Invited and contributed presentations will cover a wide range of topics from non-clinical statistics, preclinical discovery, clinical development, post-licensure evidence generation, to regulatory science, data science and statistics. A series of short courses will be given on site (may also given virtually at the same time if there is enough registration for this virtual option) by experts in their respective professional fields. The Statistics in Biopharmaceutical Research will publish a special issue of high-quality papers presented (including poster presentation) at the Symposium via a peer-review process according to the policy and principles of the journal.
This symposium is co-sponsored by several organizations. For a complete list, please visit the sponsor page.
If you are a medical/drug development professional or are interested in this quantitative field, we sincerely invite you to join us at this event.
The ISBS 2024 7th Symposium Organizing Committees.